SCYNEXIS, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
SCYNEXIS, Inc. (SCYX) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$527.00 thousand for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-19.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2015-10-30
- SCYNEXIS, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-06-30 was -$356.00K.
- SCYNEXIS, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-03-31 was -$171.00K.
- SCYNEXIS, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2014-12-31 was -$72.00K.
- SCYNEXIS, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2014-09-30 was -$309.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2015-06-30 | -$356.00K derived: 10-Q 6 month − 8-K 3 month · filed 2015-08-19 | -$527.00K 10-Q · filed 2015-08-19 | -$599.00K derived: sum of 3 quarters · filed 2015-10-30 | -$908.00K derived: sum of 4 quarters · filed 2015-10-30 |
| 2015-03-31 | -$171.00K 8-K · filed 2015-10-30 | -$243.00K derived: sum of 2 quarters · filed 2015-10-30 | -$552.00K derived: sum of 3 quarters · filed 2015-10-30 | -$585.00K derived: sum of 4 quarters · filed 2015-10-30 |
| 2014-12-31 | -$72.00K derived: 8-K 12 month − 10-Q 9 month · filed 2015-10-30 | -$381.00K derived: sum of 2 quarters · filed 2015-10-30 | -$414.00K derived: sum of 3 quarters · filed 2015-10-30 | -$488.00K 8-K · filed 2015-10-30 |
| 2014-09-30 | -$309.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$342.00K derived: sum of 2 quarters · filed 2015-08-19 | -$416.00K 10-Q · filed 2014-11-13 | -$477.00K derived: sum of 4 quarters · filed 2015-10-30 |
| 2014-06-30 | -$33.00K derived: 10-Q 6 month − 8-K 3 month · filed 2015-08-19 | -$107.00K 10-Q · filed 2015-08-19 | -$168.00K derived: sum of 3 quarters · filed 2015-10-30 | -$223.00K derived: sum of 4 quarters · filed 2015-10-30 |
| 2014-03-31 | -$74.00K 8-K · filed 2015-10-30 | -$135.00K derived: sum of 2 quarters · filed 2015-10-30 | -$190.00K derived: sum of 3 quarters · filed 2015-10-30 | |
| 2013-12-31 | -$61.00K derived: 8-K 12 month − 10-Q 9 month · filed 2015-10-30 | -$116.00K derived: sum of 2 quarters · filed 2015-10-30 | $557.00K 8-K · filed 2015-10-30 | |
| 2013-09-30 | -$55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $618.00K 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $673.00K 10-Q · filed 2014-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |